Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc > RBC Estimate $17.64/boe Netback in 2020.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(30)
•••
Comment by skiptoggleon Nov 29, 2019 10:29am
159 Views
Post# 30405361

RE:RE:RE:RE:RBC Estimate $17.64/boe Netback in 2020.

RE:RE:RE:RE:RBC Estimate $17.64/boe Netback in 2020.
Cash flow per share(after tax earnings) is estimated at $0.64 in 2020 according to RBC.


Maxmoe wrote: Skip,I don't get RBC research, but I'm curious because pipe is not broadly covered yet, what is the eps forecast from RBC? 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities